Global Fill-finish Pharmaceutical Contract Manufacturing Market Size study, By Molecule Type (Large Molecules, Small Molecules), By Product Type (Prefilled Syringes, Vials, Cartridges, Others), By End-user (Biopharmaceutical Companies, Pharmaceutical Comp

Global Fill-finish Pharmaceutical Contract Manufacturing Market Size study, By Molecule Type (Large Molecules, Small Molecules), By Product Type (Prefilled Syringes, Vials, Cartridges, Others), By End-user (Biopharmaceutical Companies, Pharmaceutical Companies), and Regional Forecasts 2022-2028

Global Fill-finish Pharmaceutical Contract Manufacturing Market is valued at approximately USD 8.25 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.0% over the forecast period 2022-2028. Fill finish manufacturing is a method that involves aseptically filling of medicines or biological drugs in a form such as sterile liquid, powder, and suspension, in vials, ampoules, bottle syringes, and cartridges. Factors such as the growing number of technological developments in fill-finish manufacturing processes, the flourishing development of the biopharmaceutical industry, coupled with the increasing adoption of prefilled syringes for parenteral dosage forms are impelling the global market growth. For instance, as per Statista, in 2018, the biopharmaceutical industry worldwide was estimated to be accounted for USD 5.28 trillion and the amount rises and reached USD 7.15 trillion in 2021. Consequentially, the development of the biopharmaceutical industry is burgeoning the market demand across the globe. However, high costs associated with isolators or RABS and several problems associated with maintaining sterility in fill-finish manufacturing operations impede the growth of the market over the forecast period of 2022-2028. Also, the rising investments in drug development and substantial development of the emerging markets are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Fill-finish Pharmaceutical Contract Manufacturing Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing number of biopharmaceutical and pharmaceutical companies and rising expenditure on drug development. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the improving healthcare infrastructure facilities, as well as growing investment by the companies in clinical research, would create lucrative growth prospects for the Fill-finish Pharmaceutical Contract Manufacturing Market across the Asia-Pacific region.

Major market players included in this report are:
Boehringer Ingelheim
Catalent Inc
Recro Pharma, Inc.
Baxter’s BioPharma Solutions
Eurofins Scientific
Symbiosis Pharmaceutical Service
MabPlex International Co. Ltd.
Recipharm AB
Fresenius Kabi Contract Manufacturing
Novartis

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Molecule Type:
Large Molecules
Small Molecules
By Product Type:
Prefilled Syringes
Vials
Cartridges
Others
By End-user:
Biopharmaceutical Companies
Pharmaceutical Companies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Fill-finish Pharmaceutical Contract Manufacturing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors



Companies Mentioned

Boehringer Ingelheim
Catalent Inc
Recro Pharma, Inc.
Baxter’s BioPharma Solutions
Eurofins Scientific
Symbiosis Pharmaceutical Service
MabPlex International Co. Ltd.
Recipharm AB
Fresenius Kabi Contract Manufacturing
Novartis

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.